Skip to content
value.today

Collaborative Network 4 Clinical Excellence, Inc.

Total raised
$6 M
2 rounds on record
Latest round
$3 M
May 2025
First round on record
Apr 2024
Today
Private
No later event on record

Funding rounds

2 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Collaborative Network 4 Clinical Excellence, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
May 2025$3 MNo. 2$2 to $10 million

Collaborative Network 4 Clinical Excellence, Inc.: Raise no. 2, May 2025

Investors in this round

19 investors had bought by the notice of Feb 26, 2026: 19 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $3 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Haluk Yilmazturk · Executive Officer, Director
  • Mehmet Kazgan · Executive Officer, Director
  • Jae Lee · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Proceeds are to be used for general working capital purposes, which may include payment of ordinary course remuneration to officers.”

Signed by Haluk Yilmazturk, Treasurer. Source: SEC Form D, newest notice filed Feb 26, 2026. Read the notice at the SEC.

equitySEC
Apr 2024$3 MNo. 1$2 to $10 million

Collaborative Network 4 Clinical Excellence, Inc.: Raise no. 1, Apr 2024

Investors in this round

18 investors had bought by the notice of Feb 11, 2025: 18 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $3 M offered; $0 M still to sell
Smallest investment taken
$10,000
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Haluk Yilmazturk · Executive Officer
  • Mehmet Kazgan · Executive Officer, Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Proceeds are to be used for general working capital purposes, which may include payment of ordinary course remuneration to officers.”

Signed by Mehmet Kazgan, CEO and President. Source: SEC Form D, newest notice filed Feb 11, 2025. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Collaborative Network 4 Clinical Excellence, Inc. chose not to state its revenue in its newest notice of a funding round (Feb 2026).

    SEC Form D · Feb 2026

  • The industry group it chose in its notices: Other Technology.

    SEC Form D · Feb 2026

That is all the official record says: Collaborative Network 4 Clinical Excellence, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Collaborative Network 4 Clinical Excellence, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 19 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Collaborative Network 4 Clinical Excellence, Inc.
NameRoleNamed in
Haluk YilmazturkExecutive officerFeb 2026
Mehmet KazganExecutive officerFeb 2026
Haluk YilmazturkDirectorFeb 2026
Jae LeeDirectorFeb 2026
Mehmet KazganDirectorFeb 2026